Literature DB >> 22255918

Design of a new probe for tumor treatment in the alternate thermal system based on numerical simulation.

Zhanghao Cai1, Mingyang Song, Jianqi Sun, Aili Zhang, Lisa X Xu.   

Abstract

A new probe for tumor treatment is designed and simulated in this study. This probe combines the cryosurgery and hyperthermia which is suitable for the treatment of subcutaneous tumors. Simulations of the cooling and heating processes demonstrate that the probes are capable of treating the tumor effectively. And the numerical results indicate that the lengths of the probe, the diameters of the inner tube and the pressures of liquid nitrogen influence the probes' cooling ability. The temperature responses at the tumor base induced by different probes are similar, though the great differences appear on the treatment interface of the probes, thus the temperature gradient within the tumor. Based on the simulation results, the heating effect of the probe is shown to be effective in damaging the tumor while protecting normal tissue in the surrounding. Animal experiments will be carried out using this type of probe to treat tumor in the near future.

Entities:  

Mesh:

Year:  2011        PMID: 22255918     DOI: 10.1109/IEMBS.2011.6091695

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response.

Authors:  Kun He; Ping Liu; Lisa X Xu
Journal:  Cell Death Dis       Date:  2017-03-23       Impact factor: 8.469

2.  Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity.

Authors:  Kun He; Shengguo Jia; Yue Lou; Ping Liu; Lisa X Xu
Journal:  Cell Death Dis       Date:  2019-03-04       Impact factor: 8.469

3.  Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation.

Authors:  Jun Zhu; Yan Zhang; Aili Zhang; Kun He; Ping Liu; Lisa X Xu
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.